Completed Access to Information Requests

Transitional Period

Federal departments are moving their web content to Canada.ca. As a part of that process, proactive disclosure reports will become available through the Open Government portal.  During this transition, if a proactive disclosure report from a specific department is not yet available on the Open Government portal please refer to Proactive disclosure by department or agency where a copy can be found.  For any questions on this issue, please contact us at open-ouvert@tbs-sct.gc.ca .

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests previously made to the Government of Canada. If you find a summary of interest, you can request a copy of the records at no cost. For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator.

Enter keywords (e.g. institution, topic, field of interest, etc.)
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Found 219 record(s)

Req # A-2018-000588

Adverse Reaction Report (AER) for PANTOPRAZOLE MAGNESIUM. Report numbers: 000709317, 000711614.

Organization: Health Canada

22 page(s)
August 2018

Req # A-2015-000232

Adverse Reaction Report (AER) for Celexa (citalopram). Report numbers: 000639223, 000640670, 000644685, 000646898.

Organization: Health Canada

66 page(s)
August 2018

Req # A-2016-001479

Statistical tables of drug losses reported to Health Canada from January 1, 2016 to December 31, 2016 for Saskatchewan and Manitoba.

Organization: Health Canada

104 page(s)
August 2018

Req # A-2014-000153

Health Canada guideline Safety Code 6, Limits of Human Exposure to Radiofrequency Electromagnetic Energy in the Frequency Range from 3 kHz to 300 GHz conducted between May 16, 2014 and July 15, 2014.

Organization: Health Canada

926 page(s)
August 2018

Req # A-2016-001480

Statistical tables of drug losses reported to Health Canada from January 1, 2016 to December 31, 2016 for Ontario.

Organization: Health Canada

532 page(s)
August 2018

Req # A-2015-000220

All correspondence received or sent by certain organizations related to the Canada Food Guide in the 24 months preceding September 22, 2015.

Organization: Health Canada

80 page(s)
August 2018

Req # A-2014-000227

All documents relating to the adverse effects reported to Health Canada concerning so-called energy drinks (i.e., Red Bull, Monster) in the period from January 1, 2008 to December 31, 2014.

Organization: Health Canada

270 page(s)
August 2018

Req # A-2016-001512

A list of all files stored locally on Denis Choiniere's computer relating to public policy on the date of this request January 13, 2017.

Organization: Health Canada

26 page(s)
August 2018

Req # A-2014-000279

Copy of the Abbreviated New Drug Submission (ANDS), reviewer's report and all correspondence related to Docetaxel for Injection 20 mg/mL, Accord HealthCare, Drug Identification Number (DIN) 02437031.

Organization: Health Canada

5089 page(s)
August 2018

Req # A-2015-000013

All records received during the period January 1, 2012 to March 27, 2015 concerning the safety of, adverse reactions to, or regulatory status of Quorn or mycoprotein.

Organization: Health Canada

346 page(s)
August 2018